Sensex, Nifty fall as pharma shares weigh; Pfizer Indian unit jumps
Indian shares fell on Monday, weighed down through losses in pharmaceutical shares, despite the fact shares of Pfizer Inc's Indian arm jumped on high-quality information for the dad or mum company's experimental tablet towards COVID-19.
The blue chip NSE Nifty 50 index fell 0.30% to 17,863.05 and the benchmark S&P BSE Sensex fell 0.29% to fifty nine,895.forty via 9:31 am.
Markets had won in Thursday's special one-hour trading session and have been shut on Friday for the festive season of Diwali.
On Monday, shares of Pfizer Ltd received as a whole lot as 8.three% after its guardian referred to on Friday that its experimental COVID-19 antiviral tablet cut through 89% the opportunity of hospitalization or demise for adults prone to severe disease.
The Nifty Pharma Index misplaced 1.ninety seven%, weighed down by way of a 7.9% fall in active pharmaceutical ingredient maker Divi's Laboratories, regardless of the company posting mighty September-quarter results on Saturday.
Divi's makes the API for regularly occurring versions of Pfizer rival Merck's COVID-19 antiviral capsule molnupiravir.
Broader Asian markets have been blended as buyers looked forward to a reading on U.S. inflation later in the week.
Comments
Post a Comment